Navigation Links
MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
Date:9/11/2007

preferred shares into 158,342 common shares in respect of a milestone achieved in the MX-2401 program in April 2007. As of August 31, 2007 the 4,000,000 Series E preferred shares representing potential milestone payments of US$4,000,000 can be redeemed for the aggregate sum of US$1 following the expiry of the milestone obligations associated with these preferred shares.

----------------------------------------------------------------------- --

Conference Call

Investors, analysts and the media are invited to participate in a conference call Tuesday September 11, 2007 at 11:00 a.m. ET (8:00 a.m. PT) to discuss this announcement. To participate in the conference call, please dial 416-644-3415 or 1-800-732-9303. The call will be available for replay until September 25, 2007 by calling 416-640-1917 or 1-877-289-8525 and entering the pass code 21244947 followed by the number sign. The live and archived web cast can be accessed through the company's website at http://www.migenix.com for the next 90 days.

-------------------------------------------------------------------------

Selected Financial Highlights

BALANCE SHEETS July 31, April 30,

Unaudited - In Thousands of Canadian dollars 2007 2007

-------------------------------------------------------------------------

Assets

Cash and cash equivalents $7,376 $2,945

Short-term investments 5,437 12,365

Other current assets 1,318 1,245

-------------------------------------------------------------------------

Total current assets $14,131 $16,555

Long-term investments 1 1

Equipment 928
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), ... protected regenerative biomaterials and bioimplants processed from human ... clinical study.    The study article, ... Trial Evaluating the Use of Dehydrated ... Therapy vs. Multi-layer Compression Therapy Alone in the ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Immunomic Therapeutics, ... Innovation Research (SBIR) grant to support the continued preclinical ... provide ITI with approximately $255,000 over one year to ... cause of food allergy, affect over one million Americans ... peanut allergy. Tree nut exposure is also a risk ...
(Date:9/17/2014)... , Sept. 17, 2014 Alternative Fuels Americas, ... to form a Special Purpose Vehicle in partnership with Jatro ... centric agro energy company. The SPV shall be called AFAI ... with AFAI as majority shareholder. The SPV shall pursue Jatropha ... , particularly Ethiopia . ...
(Date:9/17/2014)... FOREST, California , 17 de septiembre ... CYRX) ("la compañía"), principal proveedor mundial de ... de las ciencias de la vida, anunció ... compañía de logística global con sede en ... su base de clientes Europa en rápido ...
Breaking Biology Technology:MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 2MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 3MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 4Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 2Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 3AFAI Signs Joint Venture Agreement With Jatro Greentech Inc. 2AFAI Signs Joint Venture Agreement With Jatro Greentech Inc. 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 2Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 4Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 5
... Compendia Bioscience, Inc.,today announced the release and ... high-value product extension of Oncomine,Research Edition for ... includes custom gene filters, integration with Ingenuity,Pathway ... Concepts Map,including the ability to upload custom ...
... Offer Full Range of Fertility Services and ... Dr. John Jain, a,fertility specialist with ... the,country, announced today the grand opening of ... reproductive health center in Santa,Monica, California. The ...
... Features ... Renowned Investment Banker and Biotechnology Company Start-up Leader ... Stelios Papadopoulos, PhD Provides Keynote Address, BOSTON, ... Opportunities Investor Conference, New,England,s largest biotechnology investor forum, will ...
Cached Biology Technology:Compendia Bioscience Announces the Release and Availability of Oncomine(TM) Research Premium Edition 2Pioneer in Reproductive Medicine Opens The Country's First Comprehensive Fertility Practice 22007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies 22007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies 3
(Date:9/17/2014)... from the Copenhagen Centre for Social Evolution and Yale ... that birth weight and -length can partially predict the ... as autism and schizophrenia later in life. The study ... subsequent hospital diagnoses for up to 30 years, and ... study is published today in the Proceedings of ...
(Date:9/17/2014)... Biomedical Research Institute (ICO-IDIBELL), led by David Garcia-Mollev ... accompanying cells in colorectal tumors. Analysis of these ... predict the evolution of the patient and thus ... Biomarkers , Colorectal cancer is ... sexes. About 30,000 new cases are diagnosed each ...
(Date:9/17/2014)... DC A team of researchers working on a Carnegie ... coral growth rates have plummeted 40% since the mid-1970s. ... an important role in this perilous slowdown. , ... facing coral reefs, the team compared current measurements of ... Barrier Reef with similar measurements taken more than 30 ...
Breaking Biology News(10 mins):Size at birth affects risk of adolescent mental health disorders 2Size at birth affects risk of adolescent mental health disorders 3Five genes to predict colorectal cancer relapses 2Coral growth rate plummets in 30-year comparison 2
... Technology (Caltech) have devised a new techniqueusing a sheet ... of molecules. The technique, which was used to obtain ... at room temperature, can also be used to image ... and other biomolecules. A paper describing the method ...
... prototype model of the first implantable artificial kidney, in ... for dialysis. The device, which would include thousands ... mimic the metabolic and water-balancing roles of a real ... engineers, biologists and physicians nationwide, led by Shuvo Roy, ...
... is a joke no more. In a special September issue ... ( CBE-LSE ), the adage that biology is for science ... "Bio-math" or "math-bio" is in the future for students of ... research articles on new ways to integrate mathematical thinking into ...
Cached Biology News:Caltech chemists develop simple technique to visualize atomic-scale structures 2Caltech chemists develop simple technique to visualize atomic-scale structures 3UCSF unveils model for implantable artificial kidney to replace dialysis 2UCSF unveils model for implantable artificial kidney to replace dialysis 3You say, 'bio-math,' I say, 'math-bio': Crossing science education divide 2
Amino Acid Analysis is performed using ion-exchange separation of the amino acids from acid hydrolysates, followed by ninhydrin detection. Typical quantities required are 0.1 to 0.5 mg, depending on...
ANTI CORTIS BIN GLOB...
ANTI S. ENTERID LPS...
... This DuoSet ELISA Development kit contains ... of sandwich ELISAs to measure natural and ... and serum. Each kit contains sufficient ... 96-well plates, provided that the following conditions ...
Biology Products: